Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ammonia detoxification pathways and intestinal lumen pH refer to the integrated physiological mechanisms responsible for maintaining low systemic ammonia levels. Ammonia is primarily generated in the gastrointestinal tract through the action of bacterial urease on urea and the deamination of amino acids (StatPearls, 2023). Under normal conditions, the liver detoxifies this ammonia via the urea cycle; however, in patients with cirrhosis or urea cycle disorders, ammonia accumulates and crosses the blood-brain barrier, causing neurotoxicity (NIH, 2022). Therapeutic strategies often target the intestinal lumen pH to facilitate ammonia clearance. For example, non-absorbable disaccharides like lactulose are fermented by colonic flora into lactic and acetic acids, which lowers the pH and traps ammonia as non-absorbable ammonium ions (NH4+) (PubMed, 2021). Additionally, drugs may target the production of ammonia by inhibiting gut bacteria or provide alternative nitrogen disposal pathways through scavenging agents like sodium phenylbutyrate (FDA, 2013). Consequently, this "target" encompasses a broad range of metabolic and environmental factors critical for managing hyperammonemia.
The primary mechanism involves the acidification of the colonic contents via the bacterial fermentation of non-absorbable sugars, which converts ammonia (NH3) into the non-absorbable ammonium ion (NH4+), thereby preventing its systemic absorption (PubMed, 2021). Additionally, the reduction of urease-producing gut microbiota and the stimulation of alternative nitrogen excretion pathways (e.g., via phenylacetate conjugates) contribute to lowering systemic ammonia levels (StatPearls, 2023).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ammonia detoxification pathways and intestinal lumen pH.